STAM expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.216800E-01
Normal-vs-Stage2
5.952800E-01
Normal-vs-Stage3
8.157200E-01
Normal-vs-Stage4
1.756420E-01
Stage1-vs-Stage2
6.824200E-01
Stage1-vs-Stage3
6.410400E-01
Stage1-vs-Stage4
4.169800E-01
Stage2-vs-Stage3
7.877800E-01
Stage2-vs-Stage4
1.790010E-01
Stage3-vs-Stage4
3.141800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.014200E-01
Normal-vs-AfricanAmerican
4.681000E-01
Normal-vs-Asian
9.466200E-01
Caucasian-vs-AfricanAmerican
3.761200E-01
Caucasian-vs-Asian
3.965800E-01
AfricanAmerican-vs-Asian
2.852400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.112000E-01
Normal-vs-Female
5.531800E-01
Male-vs-Female
9.666600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.322600E-01
Normal-vs-Age(41-60Yrs)
3.555400E-01
Normal-vs-Age(61-80Yrs)
7.161600E-01
Normal-vs-Age(81-100Yrs)
6.380800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.072600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.830600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.093200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.222400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.412200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.961600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.000600E-01
Normal-vs-Daily Drinker
9.994000E-01
Normal-vs-Weekly Drinker
5.733800E-01
Normal-vs-Occasional Drinker
4.218000E-01
Normal-vs-Social Drinker
8.333400E-01
Non Drinker-vs-Daily Drinker
7.951200E-01
Non Drinker-vs-Weekly Drinker
3.578800E-01
Non Drinker-vs-Occasional Drinker
1.128960E-01
Non Drinker-vs-Social Drinker
8.067600E-01
Daily Drinker-vs-Weekly Drinker
2.973600E-01
Daily Drinker-vs-Occasional Drinker
1.014780E-01
Daily Drinker-vs-Social Drinker
6.748000E-01
Weekly Drinker-vs-Occasional Drinker
6.128600E-01
Weekly Drinker-vs-Social Drinker
6.081600E-01
Occasional Drinker-vs-Social Drinker
3.125200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.942200E-01
Normal-vs-Grade 2
6.174200E-01
Normal-vs-Grade 3
6.427600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.481700E-02
Grade 1-vs-Grade 3
2.377800E-01
Grade 1-vs-Grade 4
3.942200E-01
Grade 2-vs-Grade 3
5.765200E-01
Grade 2-vs-Grade 4
6.174200E-01
Grade 3-vs-Grade 4
6.427600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.221200E-01
Normal-vs-NonDiabetic
7.026200E-01
Diabetic-vs-NonDiabetic
6.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.742800E-01
Normal-vs-NoPancreatitis
6.312200E-01
Pancreatitis-vs-NoPancreatitis
3.225600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.470200E-01
Normal-vs-N1
5.998200E-01
N0-vs-N1
9.232000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.955400E-01
Normal-vs-TP53-NonMutant
8.049600E-01
TP53-Mutant-vs-TP53-NonMutant
1.046200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
